Current Statin News and Events

Current Statin News and Events, Statin News Articles.
Sort By: Most Relevant | Most Viewed
Page 1 of 21 | 839 Results
Study examines aspirin and statin use among older Americans
An analysis published in the Journal of the American Geriatrics Society indicates that while adults aged 75 years and older do not benefit from taking aspirin to prevent cardiovascular disease, many do so on a regular basis. (2021-02-18)

New data on COVID-19 patients with diabetes show that one in five die within
Updated results from the CORONADO study, analysing the outcomes of patients with diabetes admitted to hospital with COVID-19, shows that one in five patients die within 28 days while around half are discharged. The study is published in Diabetologia (the journal of the European Association for the Study of Diabetes [EASD]). (2021-02-17)

People with and without AD have a different threshold for elective revascularisation
The risk of both mortality and rehospitalisation after an elective revascularisation procedure for coronary artery disease is similar for people with and without Alzheimer's disease (AD), but people with AD had worse outcomes after an emergency procedure, according to a new study from the University of Eastern Finland. (2021-02-15)

Oncotarget: Simvastatin is a potential candidate drug in ovarian clear cell carcinomas
''Simvastatin efficiently controlled OCCC proliferation and migration, thus showing potential as a candidate drug for the treatment of OCCC.'' (2021-02-01)

Automated AI algorithm uses routine imaging to predict cardiovascular risk
Investigators teamed up to develop and evaluate a deep learning system that may help change this. The system automatically measures coronary artery calcium from CT scans to help physicians and patients make more informed decisions about cardiovascular prevention. (2021-01-29)

Statins may protect the heart from chemotherapy treatment of early breast cancer
Women who take statins, the common cholesterol-lowering medication, during chemotherapy with anthracyclines for early-stage breast cancer are half as likely to require emergency department visits or hospitalization for heart failure in the 5 years after chemotherapy. (2021-01-06)

Common drug may protect hearts from damage caused by breast cancer chemotherapy
New research from UHN's Peter Munk Cardiac Centre (PMCC) shows statins, commonly prescribed to lower cholesterol and reduce the risk of heart disease and stroke, may also protect the heart from damaging side-effects of early breast cancer treatment. (2021-01-06)

CAN risk in diabetes reduced with intensive control of blood glucose and blood pressure
Cardiovascular autonomic neuropathy (CAN), a frequent but underdiagnosed complication of diabetes that can be life-threatening. Researchers found that intensive glycemic control reduced CAN risk by 17%, while intensive blood pressure control reduced risks by 22%. (2020-12-16)

Clinical trial results address concerns about pharmacogenetic testing
Researchers conducted a randomized controlled trial of pharmacogenetic testing related to cholesterol-lowering medications called statins.After one year, the cholesterol levels in the group who received their pharmacogenetic results were not higher than those in the group who did not receive their results, and they were not less likely to receive medical care meeting recommended guidelines. (2020-12-03)

LGB adults may be less likely to take statins to prevent heart disease
Lesbian, gay and bisexual (LGB) adults are at higher risk for cardiovascular disease than non-LGB adults. Yet, LGB adults who have diabetes or high cholesterol are less likely than non-LGB adults to use statins, which help prevent cardiovascular events such as heart attacks. There is an urgent need for prevention programs aimed at reaching at-risk LGB adults to increase knowledge about the benefits of statins. (2020-12-02)

Statins can save lives, are they being used?
People who have coronary artery disease, stroke or peripheral artery disease often are prescribed a statin, a cholesterol-lowering drug that reduces the risk of heart attack or stroke. (2020-12-01)

Patients taking statins experience similar side effects from dummy pills
People taking dummy pills and statins experienced similar side effects in a new study. (2020-11-15)

Side effects often attributed to statins were the same for those taking a placebo
Study participants who reported side effects from cholesterol-lowering medications known as statins also reported the same side effects when they unknowingly took placebo pills. These side effects are real, and it appears may be mostly due to the psychological rather than the pharmacological effects of statins since symptoms were consistent when taking the placebo. (2020-11-15)

American Heart Association Scientific Sessions to feature Brigham breakthroughs
Leading cardiologists worldwide will convene virtually from November 13-17 at the American Heart Association's 2020 Scientific Sessions, sharing the latest advancements in cardiovascular science and clinical care. The three studies highlighted below represent only a sample of the cutting-edge research Brigham experts in the field will present at the conference. (2020-11-13)

The Lancet: Older adults are at greater risk of cardiovascular events than younger people, and benefit at least as much from cholesterol-lowering medications, two studies suggest
Peer-reviewed / 1 Observational study + 1 Systematic review and meta-analysis / People (2020-11-10)

Muscle pain and energy-rich blood: Cholesterol medicine affects the organs differently
Contrary to expectation, treatment with statins has a different effect on blood cells than on muscle cells, a new study from the University of Copenhagen reveals. Today, statins are mainly used in the treatment of elevated cholesterol, but the new results may help design drugs for a number of conditions. (2020-10-29)

Adults with endocrine disorders have an increased risk of heart disease
All adults with endocrine disorders should be tested for high cholesterol and triglycerides to evaluate their risk of heart attack or stroke, according to a Clinical Practice Guideline issued today by the Endocrine Society. (2020-10-28)

Yes or No: Forcing a choice increased statin prescribing for heart disease patients
Adding an 'active choice' nudge to the electronic health record increased statin prescribing for patients with heart disease, but not for those 'at-risk'. (2020-10-07)

Cholesterol drug combinations could cut health risk for European patients
More patients could benefit from combinations of cholesterol-lowering drugs to reduce their risk of stroke and heart attacks. (2020-08-28)

Scan for arterial plaque is better at predicting heart attack than stroke
The amount of calcified plaque in the heart's arteries is a better predictor of future heart attacks than of strokes, with similar findings across sex and racial groups, according to new research from UT Southwestern. (2020-08-18)

Food-based approach to lowering cholesterol provides significant healthcare cost savings
A new study is the first to show a food-based approach using clinically-proven diet interventions to lower cholesterol levels, such as Step One Foods®, provides significant healthcare cost savings. (2020-08-13)

Among older adults, statin use tied to decreased risk of death
A new study led by investigators from Brigham and Women's Hospital and the VA Boston Healthcare System leverages national data from the U.S. Veterans Health Administration Services and Centers for Medicare & Medicaid Services to shed new light on the role statins may play for older adults who have not yet experienced a heart attack, stroke or other cardiovascular event. (2020-07-07)

Coronary calcium scoring: Personalized preventive care for those most at risk
An imaging test called coronary calcium scoring can help doctors to make the right recommendation about the use of statin therapy. The test is a 10-minute CT (computed tomography) scan looking for calcium deposits in the arteries supplying blood to the heart. Calcium deposits indicate the presence of coronary plaque, also known as atherosclerosis. (2020-07-06)

Twitter data research reveals more about what patients think about statins
More than one in seven people taking statins -- prescribed to lower cholesterol levels -- believed that meant they could still eat unhealthy foods, a new study shows. (2020-06-25)

Statin use is linked to lower death rate in hospitalized COVID-19 patients
The use of cholesterol-lowering drugs called statins is associated with a lower death rate and a lower incidence of mechanical ventilation in patients hospitalized with Coronavirus disease 2019 (COVID-19), researchers report June 24 in Cell Metabolism. The large-scale retrospective study also showed that mortality risk and other negative outcomes were not increased by combination therapy consisting of statins and blood pressure-lowering drugs called angiotensin-converting enzyme (ACE) inhibitors and angiotensin II receptor blockers (ARBs). (2020-06-24)

Should nursing home residents nearing the end of life continue taking statins?
A team of researchers conducted a study to learn more about statin use among older adults, especially those nearing the end of their lives. The study, published in the Journal of the American Geriatrics Society, evaluated statin use by people with life-limiting conditions across nearly all U.S. nursing homes. The researchers hoped to identify statin use among nursing home residents who were unlikely to benefit from treatment. (2020-06-24)

New nanoparticle drug combination for atherosclerosis
Physicochemical cargo-switching nanoparticles (CSNP) designed by KAIST can help significantly reduce cholesterol and macrophage foam cells in arteries, which are the two main triggers for atherosclerotic plaque and inflammation. (2020-06-17)

Improved gut microbiota with cholesterol-lowering medication
There is a clear link between improved gut microbiota and one of our most common cholesterol-lowering drug groups: statins. This is evident from a European study involving researchers from the University of Gothenburg. (2020-06-15)

Genetic risk scores may improve clinical identification of patients with heart attack risk
Researchers at Mass General and the Broad Institute have found that applying polygenic risk scores can identify patients at risk of a heart attack who may be missed in standard clinical evaluations. (2020-06-02)

Pulmonary embolism and COVID-19
Researchers at Henry Ford Health System in Detroit say early diagnosis of a life-threatening blood clot in the lungs led to swifter treatment intervention in COVID-19 patients. In a new study published recently in the journal Radiology, researchers found that 51 percent of patients found to have a pulmonary embolism, or PE, were diagnosed in the Emergency Department, the entry point for patients being admitted to the hospital. (2020-06-02)

Some recommended cardiovascular medications prescribed less frequently to women
In primary care, sex differences for recommended cardiovascular (CVD) prescriptions were found for patients who were at high risk or who had CVD. Women were less likely than men to receive cholesterol-lowering medicines and aspirin, yet equally likely to receive blood-pressure-lowering medications. (2020-05-20)

Heart attack prevention lags for people with stroke, peripheral artery disease
Although all three conditions can lead to heart attack, people with stroke or peripheral artery disease were less likely to receive preventive treatments to prevent heart attack than people with coronary artery disease. Stroke survivors were more likely to report poor health care satisfaction and more emergency room visits. Patients with peripheral artery disease had the highest out-of-pocket health expenses of the three conditions. (2020-05-16)

Icosapent ethyl found to significantly reduce revascularizations in statin patients
Patients with high lipid levels have an increased risk for ischemic events, despite statin therapy. Findings presented as late-breaking science during the SCAI 2020 Scientific Sessions Virtual Conference revealed that for statin-treated patients with elevated triglycerides and increased cardiovascular risk, icosapent ethyl significantly reduced first and subsequent revascularizations compared with placebo. (2020-05-14)

Obesity is linked to gut microbiota disturbance, but not among statin-treated individuals
In 2012, the European Union MetaCardis consortium (www.MetaCardis.net), comprising 14 research groups from six European countries with multidisciplinary expertise set out to investigate a potential role of the gut microbiota in the development of cardio-metabolic diseases. This project, coordinated by Prof Karine Clément at INSERM (France) studies more than 2,000 deeply phenotyped European participants in health and at different stages of cardiometabolic disease (obesity, diabetes and cardiovascular diseases). (2020-05-06)

Cholesterol lowering drugs linked to improved gut bacteria composition in obese people
Obese Europeans who are treated with cholesterol lowering drugs have not only lower values of blood LDL cholesterol and markers of inflammation but in addition a more healthy gut bacteria profile than those obese who are not prescribed statins. This is reported in a new study in Nature by the EU-funded MetaCardis consortium. (2020-05-06)

PCSK9 inhibitor with statin does not cause loss in memory, mental skills in high-risk patients
Heart disease patients taking evolocumab in addition to a statin to achieve extremely low levels of cholesterol do not show increased incidence of neurocognitive impairments, including memory loss or reduction in executive functions (mental skills), while at the same time have a decrease in recurrent cardiovascular events such as stroke and heart attack, according to a study published in the Journal of the American College of Cardiology that examined the cognitive function of the entire FOURIER cohort at two years. (2020-05-04)

Statins may protect against the heart harms of breast cancer therapies
Statins are widely used to lower cholesterol and prevent heart disease and related deaths, but can they also help guard against heart damage caused by certain breast cancer therapies? New research being presented at the American College of Cardiology's Annual Scientific Session Together with World Congress of Cardiology (ACC.20/WCC) suggests the answer may be yes. (2020-03-19)

Statins starve cancer cells to death
More than 35 million Americans take statin drugs daily to lower their blood cholesterol levels. Now, in experiments with human cells in the laboratory, researchers at Johns Hopkins Medicine have added to growing evidence that the ubiquitous drug may kill cancer cells and have uncovered clues to how they do it. (2020-03-12)

Research suggests statins could lower ovarian cancer risk
A genetic study has found evidence to suggest that women who take statins in the long term could be less likely to develop ovarian cancer. (2020-02-18)

Low-dose methotrexate associated with small increase in some adverse events
A pre-specified secondary analysis of a double-blind placebo-controlled randomized trial found that low-dose methotrexate (LD-MTX) was associated with a small to modest increase in the risk for some adverse events, including skin cancer and gastrointestinal, infectious, pulmonary, and hematologic effects in patients at risk for heart disease. The risk for kidney-related side-effects was decreased. The findings are published in Annals of Internal Medicine. (2020-02-17)

Page 1 of 21 | 839 Results
   First   Previous   Next      Last   
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.